AzTrials
AzTrials

Shoulder Musculoskeletal DisordersORTHOSLEEPNCT06854913

Impact of Orthopedic Surgery on Workers' Sleep

A study testing Post-Operative monitoring using wearable biosensor and Usability Assessment and Patient Willingness to Use Technology Description in people with Shoulder Musculoskeletal Disorders, run by Fondazione Policlinico Universitario Campus Bio-Medico at 1 site in Italy.

Enrolling by invitation

Enrolling by invitation. The study team selects and invites participants, usually from an existing group of patients.

Sites and contacts
Official record
Search all trials

Trial summary

Goal: The clinical investigation aims to evaluate the impact of orthopedic shoulder surgery on sleep quality and functional recovery in workers with shoulder musculoskeletal disorders. This will be assessed through validated questionnaires and physiological monitoring using wearable sensors. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Shoulder Musculoskeletal Disorders
What is being tested?
Post-Operative monitoring using wearable biosensor and Usability Assessment and Patient Willingness to Use Technology Description
Could I receive a placebo?
No, everyone receives an active treatment
How many people
30 participants
Where
1 siteItaly
Study dates
3 Mar 2025to Jun 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Informed consent obtained.
  • Age ≥ 18 years.
  • Good understanding of spoken and written Italian.
  • Diagnosis of shoulder musculoskeletal disorders.
  • Employment in a physically demanding job requiring frequent upper limb activity.
  • Workers scheduled to undergo orthopedic shoulder surgery.
  • Workers who have accepted the surgical treatment.

Who cannot join

  • Patients with sleep disorders.
  • Patients undergoing pharmacological treatments that could potentially affect sleep patterns (e.g., antidepressants, hypnotics, and stimulants).
  • Failure to sign informed consent.
  • Patients with neuromuscular diseases.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Italy1 site
  • Fondazione Policlinico Universitario Campus Bio-Medico

    Rome, Italy, 00128

Other trials in Italy

About this study

Goal: The clinical investigation aims to evaluate the impact of orthopedic shoulder surgery on sleep quality and functional recovery in workers with shoulder musculoskeletal disorders. This will be assessed through validated questionnaires and physiological monitoring using wearable sensors.

Participant Population: The study will enroll at least 30 participants diagnosed with shoulder musculoskeletal disorders, such as rotator cuff tears, adhesive capsulitis, and glenohumeral osteoarthritis. Participants must be employed in physically demanding jobs that require frequent upper limb activity and are scheduled for orthopedic shoulder surgery.

Read more

Main Questions:

  • How does post-operative rehabilitation influence sleep quality and functional recovery in workers with shoulder musculoskeletal disorders?
  • To what extent does post-operative rehabilitation improve pain management and overall quality of life in these patients?
  • How do patients perceive the usability and comfort of wearable sensors during their rehabilitation process?

Participant Tasks:

  • Initial Assessment: Comprehensive clinical evaluation, including demographic and anthropometric data collection, and administration of the Pittsburgh Sleep Quality Index (PSQI).
  • Wearable Sensor Training: Instruction on the proper use of the Medtronic Zephyr BioPatch™ wearable biosensor for monitoring physiological and postural signals.
  • Sleep Monitoring: Participants will undergo sleep assessments at three key time points: Two nights before surgery (baseline measurement); Two weeks post-surgery during early rehabilitation; 30 days into the rehabilitation program.
  • Daily Logging: Completion of the Consensus Sleep Diary each morning following sensor use.
  • Functional Assessment: Objective evaluation of shoulder functionality through validated clinical scales and range of motion (ROM) assessments.
  • Pain and Usability Evaluation: Measurement of pain reduction and usability of wearable technology using Patient-Reported Outcome Measures (PROMs).
Read the detailed description

Shoulder pain represents one of the most widespread musculoskeletal issues globally, significantly impacting workers' quality of life and productivity. This condition often leads to substantial consequences for the overall health of affected individuals, with notable effects on essential aspects such as sleep. The majority of workers with shoulder pain also experience sleep disturbances, ranging from mild discomfort to complete inability to sleep. Nighttime pain, insomnia, and the inability to sleep on the affected side are factors that negatively impact patients' sleep quality. Poor sleep quality, in addition to pain, is one of the most common symptoms that drive patients to seek treatment and, if necessary, consider undergoing surgery.

Several studies have highlighted that rehabilitation following orthopedic surgery can significantly influence patients' sleep quality. Various patient-reported outcome measures (PROMs) have been introduced to assess improvements in sleep during the rehabilitation process. An example of a PROM is the Pittsburgh Sleep Quality Index (PSQI). With the growing interest in understanding the association between post-operative rehabilitation and sleep patterns, technologies have been introduced to provide objective and quantitative measures of these changes.

The gold standard for studying sleep is polysomnography, which, due to its intrusive nature, can alter the sleep quality and profile for reasons unrelated to the surgical rehabilitation itself. Recent studies have shown that wearable sensors measuring physiological parameters (e.g., ECG, HRV) and posture, combined with advanced artificial intelligence techniques, offer the possibility to monitor sleep profiles with good reliability in a non-intrusive and real-time manner.

This study aims to use non-invasive wearable sensors and artificial intelligence algorithms to monitor patients undergoing post-operative rehabilitation following shoulder surgery. The objective is to explore in-depth the variations in sleep patterns and quality during the rehabilitation process, analyzing the relationship between sleep and recovery. This research seeks to empirically demonstrate the benefits of post-operative rehabilitation on improving the sleep quality and profile of patients with shoulder disorders.

This research is of critical importance as it provides essential insights for clinicians and workers regarding the impact of rehabilitation on sleep quality. Understanding the relationship between shoulder pain, rehabilitation, and sleep disturbances is a key clinical issue. The outcomes of this study could have significant implications for the overall management of shoulder pain, potentially enhancing clinical practices and improving healthcare for individuals affected by these conditions. In addition, this research aims to offer valuable information that will inform optimal treatment strategies, ultimately enhancing workplace productivity and overall health.

Being tested
Post-Operative monitoring using wearable biosensor, Usability Assessment and Patient Willingness to Use Technology Description
Keywords
Musculoskeletal disorders, Shoulder pain, Sleep Monitoring, Orthopedic Surgery Outcomes, Wearable Sensors
Medical subject headings
Musculoskeletal Diseases, Shoulder Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Post-Operative monitoring using wearable biosensorOther

    The protocol involves the use of the Medtronic Zephyr BioPatch™, a wearable biosensor, to monitor sleep quality and patterns in patients recovering from shoulder surgery. The device tracks physiological signals (ECG, HRV, respiratory rate) and postural changes, providing objective data on sleep profiles. Patients are assessed at three key time points: before surgery (baseline), two weeks after surgery (early recovery phase), and 30 days post-surgery (mid-recovery phase). The primary goal is to evaluate changes in sleep quality and patterns during the post-operative period, while also monitoring improvements in shoulder functionality and pain levels. This approach aims to provide insights into the relationship between sleep quality and recovery outcomes following shoulder surgery.

  • Usability Assessment and Patient Willingness to Use Technology DescriptionOther

    The usability of the Medtronic Zephyr BioPatch™ is evaluated through patient feedback and questionnaires, focusing on comfort, ease of use, and reliability. Additionally, patient willingness to continue using the wearable sensor for sleep monitoring is assessed. This evaluation helps determine the practicality and acceptance of the technology in real-world rehabilitation settings, providing insights into its potential for long-term use in clinical practice.

Study groups in NCT06854913
Study groupRoleWhat they receive
Workers with shoulder musculoskeletal disordersExperimentalWorkers with shoulder musculoskeletal disorders will be enrolled from the Unit of Traumatology and Sports Medicine of FPUCBM. Patients who meet the inclusion criteria will be provided with an explanation of the study and the experimental protocol. After consenting to participate in the study and signing the informed consent, demographic and anthropometric data will be collected and registered on a database shared among authorized investigators involved in the project. In addition, patients will receive detailed verbal and written instructions on how to use the Medtronic Zephyr BioPatch™ wearable biosensor (Medtronic, Inc., Annapolis, MD, USA) for sleep monitoring. They will also be trained on how to complete the Consensus Sleep Diary, which they will fill out each morning after using the sensor. Sleep monitoring will be conducted at three key time points to assess changes in sleep patterns during the study. The first assessment will occur over two consecutive nights prior to surgery,
Receives: Other: Post-Operative monitoring using wearable biosensor; Other: Usability Assessment and Patient Willingness to Use Technology Description

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Heart Rate Evaluation During Sleep Across Different Rehabilitation Phases

    Heart rate will be monitored using wearable sensors during sleep across different rehabilitation phases. It will be recorded in beats per minute to evaluate the physiological response to recovery and adaptation throughout the rehabilitation process.

    Measured: three key time points: before surgery (baseline), two weeks after surgery (early recovery phase), and 30 days post-surgery (mid-recovery phase)

  2. Respiratory Rate Evaluation Evaluation During Sleep Across Different Rehabilitation Phases

    Respiratory rate will be monitored using wearable sensors during sleep across different rehabilitation phases. It will be recorded in breaths per minute to assess the physiological response to recovery and adaptation throughout the rehabilitation process

    Measured: three key time points: before surgery (baseline), two weeks after surgery (early recovery phase), and 30 days post-surgery (mid-recovery phase)

  3. Change in Sleep Efficiency Across Different Rehabilitation Phases

    Sleep efficiency is defined as the percentage of total sleep time (TST) relative to the total time spent in bed (sleep opportunity). It is calculated by dividing the amount of time spent asleep by the total time in bed and multiplying by 100. This measurement will be obtained using wearable sensors. Values of 85% or higher are generally considered indicative of good sleep quality. This parameter is critical for assessing how effectively the available time for sleep is used and for identifying sleep fragmentation or disruptions.

    Measured: three key time points: before surgery (baseline), two weeks after surgery (early recovery phase), and 30 days post-surgery (mid-recovery phase)

  4. Change in Sleep Duration Across Different Rehabilitation Phases

    Sleep duration refers to the total amount of time a subject spends asleep during the night, expressed in minutes or hours. It is measured from the onset of sleep until the final awakening, excluding periods of wakefulness. The wearable device continuously tracks sleep and wake states, providing an accurate account of total sleep time. For adults, a duration of 7 to 9 hours is typically recommended. Monitoring sleep duration is essential to evaluate the restorative quality of sleep and to compare changes across different rehabilitation phases.

    Measured: three key time points: before surgery (baseline), two weeks after surgery (early recovery phase), and 30 days post-surgery (mid-recovery phase)

  5. Change in Wake After Sleep Onset (WASO) Across Different Rehabilitation Phases

    WASO is defined as the total time, in minutes, that a subject remains awake after the initial onset of sleep and before the final awakening. A wearable device records all episodes of wakefulness during the sleep period and sums them to calculate WASO. A WASO value of less than 30 minutes is generally considered normal for healthy sleep. Elevated WASO values can indicate increased sleep fragmentation, which may compromise the quality of sleep.

    Measured: three key time points: before surgery (baseline), two weeks after surgery (early recovery phase), and 30 days post-surgery (mid-recovery phase)

  6. Change in Sleep Latency Across Different Rehabilitation Phases

    Sleep latency is the duration, measured in minutes, between the moment a subject goes to bed (or turns off the lights) and the onset of sleep. The wearable device identifies the sleep onset as the first epoch classified as sleep. A sleep latency of less than 20 minutes is generally considered normal, whereas prolonged sleep latency may signal difficulties in initiating sleep, possibly due to pre-surgical anxiety or post-surgical discomfort.

    Measured: three key time points: before surgery (baseline), two weeks after surgery (early recovery phase), and 30 days post-surgery (mid-recovery phase)

Secondary outcomes (4)
  1. Change in Sleep Data among different rehabilitation phases

    This outcome involves the use of the Consensus Sleep Diary, which patients complete each morning after using the Medtronic Zephyr BioPatch™. The diary collects information on sleep patterns, including bedtime, wake time, and perceived sleep quality.

    Measured: Three key time points: before surgery (baseline), two weeks after surgery (early recovery phase), and 30 days post-surgery (mid-recovery phase).

  2. Evaluation of the usability and Comfort of Wearable Technology

    This outcome evaluates the usability and comfort of the Medtronic Zephyr BioPatch™ using validated scales, such as the System Usability Scale (SUS). SUS is a standardized tool for assessing the ease of use and overall usability of the device. The total score ranges from 0 to 100, with 0 indicating poor usability and 100 indicating excellent usability. Higher scores represent a better outcome in terms of perceived usability of the system.

    Measured: Three key time points: before surgery (baseline), two weeks after surgery (early recovery phase), and 30 days post-surgery (mid-recovery phase).

  3. Evaluation of the Objective Improvement in Shoulder Functionality

    This outcome measures the improvement in shoulder functionality using range of motion (ROM) assessments. Shoulder ROM will be evaluated using stereophotogrammetric systems during the execution of movements of clinical relevance.

    Measured: Three key time points: before surgery (baseline), two weeks after surgery (early recovery phase), and 30 days post-surgery (mid-recovery phase).

  4. Evaluation of the Reduction in Pain Levels among different rehabilitation phases

    This outcome evaluates the reduction in pain using standardized pain assessment tools, such asthe Visual Analog Scale (VAS). VAS is a self-reported measure of pain intensity, ranging from 0 (no pain) to 10 (worst pain imaginable).

    Measured: Three key time points: before surgery (baseline), two weeks after surgery (early recovery phase), and 30 days post-surgery (mid-recovery phase).

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Mar 2025
  2. Study start3 Mar 2025
  3. Primary completionJun 2026 (estimated)
  4. Study completionJun 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
30 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06854913
Sponsor's protocol ID
270.24 CET2 cbm
Other IDs
PNC0000007 - CUP: B53C22006980
Acronym
ORTHOSLEEP
Status last verified
May 2025
First submitted
12 Feb 2025
Last updated
22 May 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: The ownership of the data is of the promoter and shared with the investigators and will be managed according to the agreements between the participating institutions and with the researchers. Data Property belongs to Fondazione Policlinico Universitario Campus Bio-Medico. The personnel involved in this study will have access to all data. In agreement with the ICH-GCP, the principal investigator of the study agrees to produce a report on the study, share all the data collected as described in the Protocol, and ensure that the data are reported responsibly and consistently. The transmission or dissemination of data through scientific publications and/or presentations in congresses, conferences, seminars, and participation in multicenter studies will take place exclusively following a purely statistical processing of the same, or in any case, in an anonymous form.

Questions about this trial

What is this clinical trial studying?

A study testing Post-Operative monitoring using wearable biosensor and Usability Assessment and Patient Willingness to Use Technology Description in people with Shoulder Musculoskeletal Disorders, run by Fondazione Policlinico Universitario Campus Bio-Medico at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: enrolling by invitation, as of the sponsor's last update on 22 May 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Heart Rate Evaluation During Sleep Across Different Rehabilitation Phases (time frame: three key time points: before surgery (baseline), two weeks after surgery (early recovery phase), and 30 days post-surgery (mid-recovery phase)). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 May 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in